Ramatroban

雷马曲班

Report date: 2022/09/08 15:17:26
NME

Base Information

Drug NameRamatroban
Drug Alias NameramatrobanumramatrobanBaynasBAY-U-3405EN-137774
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKare Biosciences IncBeijing Rundekang Medical Tech Co LtdNanjing Huawe Medicine Technology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR
Related LinksWikipediaKEGG